Successfully reported this slideshow.

Indian Pharma Market - IPM Overview June 2015

14

Share

1 of 13
1 of 13

Indian Pharma Market - IPM Overview June 2015

14

Share

Major Highlights for Month of June 2015:
...................................................................
Indian Pharma Market (IPM) clocked 7928 Crs in June 2015
........................................................................
IPM grew at 14.8% for the month of June 2015
...................................................................................
Companies:

For the month of June 2015, among the top 10, Sun* grew by 27.9% followed by Pfizer at 20.2% & Abbott* at 19.0%
.........................................................................................................
23 companies crossed the growth of IPM for the month of June 2015 among top 50
...............................................................................................
Among the top 50, Wockhardt has the highest growth of 36.2% followed by AstraZeneca at 35.4% & Glenmark at 34.5 %
..................................................................................................
27 Co's showed growths more than 10% among the top 50
............................................................................................
Among the 11-20 ranked, Glenmark has the highest growth of 34.5% followed by Torrent at 28.3% & USV at 27.1%
..................................................................................................
Among the 21-30 ranked, Wockhardt has the highest growth at 36.2% followed by MSD* 31.6% & Unichem at 20.5% & Novo Nordisk at 18.9%
......................................................................................................
Among the 31-40 ranked, AstraZeneca has the highest growth at 35.4% followed by Akumentis at 33.4% & JBCPL at 27.0%
....................................................................................................
Among the 41-50 ranked, Hetero has the highest growth at 21.0% followed by Fourrts at 17.9% & Allergan at 17.8%
..............................................................................................
Among the 51-60 ranked, Boehringer grew at 79.1% followed by Eli Lilly at 39.9% & Troikaa at 38.4%
..............................................................................................
Among the 61-70 ranked, Fresenius Kabi grew at 38.8% followed by RPG at by 36.1% followed by TTK at 26.3%
..............................................
AstraZeneca enters the 500 Cr Club, Hetero 400 Crs, Troikaa 300 Crs, Tablets India 200 Crs on MAT Basis

Major Highlights for Month of June 2015:
...................................................................
Indian Pharma Market (IPM) clocked 7928 Crs in June 2015
........................................................................
IPM grew at 14.8% for the month of June 2015
...................................................................................
Companies:

For the month of June 2015, among the top 10, Sun* grew by 27.9% followed by Pfizer at 20.2% & Abbott* at 19.0%
.........................................................................................................
23 companies crossed the growth of IPM for the month of June 2015 among top 50
...............................................................................................
Among the top 50, Wockhardt has the highest growth of 36.2% followed by AstraZeneca at 35.4% & Glenmark at 34.5 %
..................................................................................................
27 Co's showed growths more than 10% among the top 50
............................................................................................
Among the 11-20 ranked, Glenmark has the highest growth of 34.5% followed by Torrent at 28.3% & USV at 27.1%
..................................................................................................
Among the 21-30 ranked, Wockhardt has the highest growth at 36.2% followed by MSD* 31.6% & Unichem at 20.5% & Novo Nordisk at 18.9%
......................................................................................................
Among the 31-40 ranked, AstraZeneca has the highest growth at 35.4% followed by Akumentis at 33.4% & JBCPL at 27.0%
....................................................................................................
Among the 41-50 ranked, Hetero has the highest growth at 21.0% followed by Fourrts at 17.9% & Allergan at 17.8%
..............................................................................................
Among the 51-60 ranked, Boehringer grew at 79.1% followed by Eli Lilly at 39.9% & Troikaa at 38.4%
..............................................................................................
Among the 61-70 ranked, Fresenius Kabi grew at 38.8% followed by RPG at by 36.1% followed by TTK at 26.3%
..............................................
AstraZeneca enters the 500 Cr Club, Hetero 400 Crs, Troikaa 300 Crs, Tablets India 200 Crs on MAT Basis

More Related Content

Indian Pharma Market - IPM Overview June 2015

  1. 1. PharmaTrac Overview June 15
  2. 2. Dataset : PharmaTrac MAT JUNE 2015 (Val in Crs)(Val in Crs) INDUSTRY DYNAMICS: 8 months of continuous double digit growths….. JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN 2012 - 13 6018 6420 6563 6546 5987 5911 5853 5712 5803 6389 6225 6087 2013 - 14 6680 6566 6537 6554 6517 6491 6485 6108 6156 6870 6954 6909 2014 - 15 7369 7296 7874 7034 7296 7432 7313 7240 7431 8084 7788 7928 11.0 2.3 -0.4 0.1 8.9 9.8 10.8 6.9 6.1 7.5 11.7 13.5 10.3 11.1 20.5 7.3 12.0 14.5 12.8 18.5 20.7 17.7 12.0 14.8 4500 5000 5500 6000 6500 7000 7500 8000 8500
  3. 3. Dataset : PharmaTrac MAT JUNE 2015 (Val in Crs)(Val in Crs) Q1-Jan-Mar; Q2- Apr-Jun; Q3- Jul-Sept; Q4- Oct-Dec; Q 2 12 Q 3 12 Q 4 12 Q 1 13 Q 2 13 Q 3 13 Q 4 13 Q 1 14 Q2 14 Q3 14 Q4 14 Q 1 15 Q 2 15 INCRE 2474 2216 1625 1280 1416 783 1117 1381 2032 2755 2201 3234 3067 QOQ DYNAMICS: Q2 15 growth at 14.8%...better than Q2 13 & 14….
  4. 4. Dataset : PharmaTrac MAT JUNE 2015 (Val in Crs)(Val in Crs) 7855 5512 4282 3502 2776 2956 3042 2915 2645 2475 204 111 246 243 451 207 33 46 54 167 15.0 14.6 17.9 8.7 16.6 12.5 4.9 12.1 18.1 25.6 0.0 5.0 10.0 15.0 20.0 25.0 30.0 0 1000 2000 3000 4000 5000 6000 7000 8000 9000 SUN* ABBOTT* CIPLA ZYDUS* MANKIND ALKEM* GSK LUPIN PFIZER* MACLEODS AV BV GR TOP CORPORATES: Sun* leads….Macleods way ahead….
  5. 5. Dataset : PharmaTrac MAT JUNE 2015 (Val in Crs)(Val in Crs) SV- Sales Val BV- Bonus Val BONUS CONTRIBUTION: Mankind dips below 14% for the 1st time…. RANK MAT JUN 15 SV AV BV CORPORATE SV AV BV GR % CONTRI TO BONUS BV % TO SV 0 0 0 IPM 90085 86814 3271 14.3 100.0 3.6 1 1 6 SUN* 8058 7855 204 15.0 6.2 2.5 2 2 8 ABBOTT* 5623 5512 111 14.6 3.4 2.0 3 3 3 CIPLA 4528 4282 246 17.9 7.5 5.4 4 4 4 ZYDUS* 3744 3502 243 8.7 7.4 6.5 5 8 1 MANKIND 3227 2776 451 16.6 13.8 14.0 6 6 5 ALKEM* 3163 2956 207 12.5 6.3 6.6 7 5 22 GSK 3075 3042 33 4.9 1.0 1.1 8 7 16 LUPIN 2960 2915 46 12.1 1.4 1.5 9 9 12 PFIZER* 2699 2645 54 18.1 1.6 2.0 10 10 7 MACLEODS 2642 2475 167 25.6 5.1 6.3  Maximum Bonus given by Mankind followed Aristo, Cipla, and Zydus*.  Mankind shows 3 rank loss after excluding the bonus component, whereas Lupin gains 1 rank.  Other companies which have high bonus component are Alkem*(206Crs) and Sun* (203Crs)
  6. 6. Dataset : PharmaTrac MAT JUNE 2015 (Val in Crs)(Val in Crs) Jun-14 Jun-15 MAT VAL MS GR CORPORATE MAT VAL MS GR 78827.5 100.00 7.2 IPM 90085.4 100.00 14.3 34736 44.07 5.8 TOP 10 39720 44.09 14.3 21978 27.88 8.7 11 - 25 25400 28.20 15.6 10517 13.34 11.8 26 - 50 11967 13.28 13.8 7149 9.07 7.9 51 - 100 8034 8.92 12.4 4447 5.64 0.5 100 + 4965 5.51 11.6 44.07 27.88 13.34 9.07 5.64 Jun-14 44.09 28.20 13.28 8.92 5.51 Jun-15 New Companies emerge: Koye, Saffron Therapeutics, Arianna, Kepler Healthcare….
  7. 7. Dataset : PharmaTrac MAT JUNE 2015 (Val in Crs)(Val in Crs) GR IPM SUN* ABBOTT* CIPLA ZYDUS* MANKIND ALKEM* GSK LUPIN PFIZER* MACLEODS 17.0 18.8 16.3 17.9 11.0 20.0 9.7 8.9 16.3 15.8 37.6 13.1 12.2 13.5 18.0 7.7 16.0 12.8 4.3 8.6 18.6 21.3 69.7 56.0 59.5 58.9 70.3 83.1 90.8 86.6 52.3 85.2 71.1 30.3 44.0 40.5 41.1 29.7 16.9 9.2 13.4 47.7 14.8 28.9 IPM SUN* ABBOTT* CIPLA ZYDUS* MANKIND ALKEM* GSK LUPIN PFIZER* MACLEODS ACUTE CHRONIC ACUTE/CHRONIC SPLIT: Chronic grows…Acute Dominates…Sun shifts towards Acute & Lupin shows balance…..
  8. 8. Dataset : PharmaTrac MAT JUNE 2015 (Val in Crs)(Val in Crs) 77.37% 22.63% INDIAN MNC 0 2000 4000 6000 ABBOTT*, 5623 GSK, 3075 PFIZER*, 2699 SANOFI INDIA, 2265 NOVARTIS , 1179 0200040006000800010000 SUN*, 8058 CIPLA, 4528 ZYDUS*, 3744 MANKIND, 3227 ALKEM*, 3163 GR VAL : 14.4 GR VAL : 13.8 INDIAN/MNC SPLIT: Indian Companies dominate & are growing above the Market…
  9. 9. Dataset : PharmaTrac MAT JUNE 2015 (Val in Crs)(Val in Crs) * Abbott + Abbott HC + Novo; Alkem + Indchemie + Cachet; Pfizer + Wyeth; Zydus + Biochem; Micro + Bal MAT VAL JUN 15 ZONE MAT VAL MS MS (G / L) GR INCRE VAL IPM 90085 100.00% 0.00% 14.3 11258 SOUTH ZONE 24218 26.88% -0.22% 13.3 2850 NORTH ZONE 23329 25.90% -0.26% 13.1 2707 WEST ZONE 20943 23.25% 0.05% 14.5 2656 EAST ZONE 18363 20.38% 0.30% 16.0 2532 ALL INDIA ONLY 3233 3.59% 0.14% 18.8 513 28% 27% 24% 21% Jun-14 28% 27% 24% 21% Jun-15 ZONAL SPLIT: South dominates…West grows fast…
  10. 10. Dataset : PharmaTrac MAT JUNE 2015 (Val in Crs)(Val in Crs) THERAPY SPLIT: Anti Infectives leads & Gastro Intestinal grows fast with along with Anti-diabetics…………..
  11. 11. Dataset : PharmaTrac MAT JUNE 2015 (Val in Crs)(Val in Crs) RANK Jun-15 Jun- 15 G/L BRAND SUBGROUP CORPORATE SV AV BV GR INCRE 0 0 IPM 90085 86814 3271 14.3 11258 1 0 MIXTARD HUMAN PREMIX ABBOTT* 432 430 2 24.4 85 2 1 AUGMENTIN AMOXYCILLIN + CLAVULANIC ACID GSK 330 330 0 30.2 77 3 1 GLYCOMET GP GLIMEPIRIDE + METFORMIN USV 307 306 1 25.5 62 4 3 MONOCEF CEFTRIAXONE ARISTO 279 194 85 24.0 54 5 1 BECOSULES VITAMIN B COMPLEX WITH VITAMIN C ONLY PFIZER* 256 249 6 11.8 27 6 -1 COREX CHLORPHENIRAMINE + CODEINE PFIZER* 240 239 1 4.7 11 7 5 LANTUS GLARGINE SANOFI INDIA 235 235 1 31.6 57 8 1 CLAVAM AMOXYCILLIN + CLAVULANIC ACID ALKEM* 225 192 33 5.8 12 9 72 JANUMET SITAGLIPTIN + METFORMIN MSD* 216 213 2 136.3 124 10 7 PHENSEDYL COUGH LINCTUS CHLORPHENIRAMINE + CODEINE ABBOTT* 215 215 0 38.9 60 11 33 SPASMO PROXYVON PLUS DICYCLOMINE + PARACETAMOL + TRAMADOL WOCKHARDT 215 215 0 80.9 96 12 -2 DEXORANGE FERROUS COMBINATION FRANCO 211 199 12 15.9 29 13 -5 VOLINI DICLOFENAC SUN* 209 188 21 -6.0 -13 14 10 GALVUS MET VILDAGLIPTIN + METFORMIN NOVARTIS 200 198 2 32.6 49 15 -1 BETADINE POVIDONE IODINE WIN-MEDICARE 190 184 6 11.9 20 16 3 SKINLITE HYDROQUINONE + MOMETASONE + TRETINOIN ZYDUS* 188 178 10 22.9 35 17 3 TAXIM CEFOTAXIME ALKEM* 187 171 16 22.6 35 18 -7 MANFORCE SILDENAFIL MANKIND 185 53 132 3.6 6 19 -6 LIV 52 HEPATIC PROTECTORS INCLUDING AYURVEDIC HIMALAYA 185 184 1 7.0 12 20 7 FORACORT FORMOTERAL + BUDESONIDE CIPLA 180 178 1 24.2 35 TOP 20 BRANDS: Mixtard rules…Skinlite , Taxim enters top 20… Janumet grows well
  12. 12. Dataset : PharmaTrac MAT JUNE 2015 (Val in Crs)(Val in Crs) 5182 Brands launched in last 24 months…271 Brands in June 15 BRAND SUBGROUP COMPANY LD MATVAL INCREVAL NI BRANDS(LAST24MONTHS) 3256 2404 SPASMO PROXYVON PLUS DICYCLOMINE+PARACETAMOL+TRAMADOL WOCKHARDT Jul-13 215 96 BIOVAC V VARICELLA VACCINE WOCKHARDT Dec-14 51 51 TRESIBA DEGLUDEC ABBOTT* Oct-13 36 21 MOX CV AMOXYCILLIN +CLAVULANIC ACID SUN* Jan-14 25 19 HYOCIMAX HYOSCINE ZYDUS* Jan-14 24 13 GLIMISAVEMV VOGLIBOSE+METFORMIN +GLIMEPIRIDE ERIS Jul-13 24 12 HEALTHOK MULTIVITAMINS +MINERALS MANKIND Aug-13 22 14 TRAJENTA DUO METFORMIN +LINAGLIPTIN BOEHRINGERINGELHEIM Jan-14 21 20 DULCOFLEX BISACODYL BOEHRINGERINGELHEIM Jan-14 20 18 GERBISA BISACODYL ZYDUS* Jan-14 19 7 REVITALH MULTIVITAMINS +MINERALS SUN* Apr-15 18 18 DOXTSL DOXYCYCLINE+LACTOBACILLUS DR. REDDYS Jun-14 17 17 MEROBAX MEROPENEM ARISTO Dec-13 17 12 FERINJECT IRON FERRIC LUPIN Feb-14 16 13 CANMAB TRASTUZUMAB BIOCON Feb-14 15 14 LIPAGLYN SAROGLITAZAR ZYDUS* Sep-13 15 9 LUMIA VITAMIN D3(CHOLECALCIFEROL) SUN* May-14 15 14 TAVERA PIPERACILLIN +TAZOBACTAM IKON REMEDIES PVTLTD Jul-14 15 15 MELBILD DECA PEPTIDE+ISOPROPYLALCOHOL+MYRISTATE+GLYCOL ALKEM* Apr-14 14 11 PEGVIR PEGYLATEDINTERFERON ALPHA 2B CIPLA Sep-13 14 11 Jun-15

×